XXII on Monday announced it had signed a binding agreement with its senior secured lender to eliminate its senior secured debt through potential debt-for-equity exchanges. Additionally, it has ...
Biotech company 22nd Century Group (NASDAQ:XXII) must be smiling today after a recent U.S. Food and Drug Administration (FDA) designation has investors celebrating. Indeed, news broke today that the ...
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions ...
22nd Century Group, Inc. (NASDAQ:XXII), is not the largest company out there, but it saw significant share price movement during recent months on the NASDAQCM, rising to highs of US$1.21 and falling ...
The average one-year price target for 22nd Century Group (NASDAQ:XXII) has been revised to 737.46 / share. This is an increase of 17,534.15% from the prior estimate of 4.18 dated June 1, 2023. The ...
In a tumultuous trading session, 22nd Century Group, Inc. (NASDAQ:XXII) stock has been battered to a 52-week low, with shares plummeting to $3.03. According to InvestingPro data, this represents a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results